MDS Coding Errors for High-Risk Medications
Summary
The facility failed to accurately code the Minimum Data Set (MDS) for 5 residents out of 12 sampled residents. For Resident 2, the MDS dated 4/24/26 showed a readmission from the hospital, a BIMS score of 3/15 indicating severe cognitive impairment, and several high-risk drug classes, but clonazepam was not included even though an order summary dated 5/4/26 showed clonazepam 0.5 mg three times daily starting 12/11/25. The ADON stated during interview that clonazepam was not identified on the MDS and therefore was not listed in the high-risk drug class section. For Resident 3, the MDS showed a hospital readmission, a BIMS score of 15/15 indicating cognitive intactness, and high-risk drug classes including hypoglycemic and opioid, but gabapentin was not coded. An order summary dated 5/4/26 showed gabapentin 300 mg every morning and 400 mg twice daily with a start date of 4/30/25. The ADON stated that gabapentin was not identified on the MDS and therefore was not listed as a high-risk drug class medication. For Resident 25, the MDS dated 3/27/26 showed a hospital admission, a BIMS score of 10/15 indicating moderate impairment, and antipsychotic use, but gabapentin was not coded even though the order summary showed gabapentin 100 mg three times daily starting 4/9/26 and the MAR showed gabapentin 300 mg three times daily from 3/1/26 through 3/27/26 with administrations completed as ordered. For Resident 16, the quarterly MDS dated 03/13/2026 did not code anticonvulsant use even though orders and MAR documentation showed gabapentin 300 mg at bedtime was administered daily throughout March 2026, and the ADON confirmed the MDS was not coded correctly. For Resident 29, the MDS did not mark anticoagulant use and instead marked antiplatelet use, even though the resident had atrial flutter, a MAR showed Xarelto 15 mg daily throughout February 2026, and the care plan referenced Xarelto as a black box medication; the ADON confirmed the resident takes an anticoagulant and does not take an antiplatelet.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.